輸入代號或公司名稱後按 Enter
1720

生達

+0.20 (+0.36%)最後更新 2026-09-15
台灣 · 上市 · 生技醫療業
56.1070成交張數9.76本益比1.62股價淨值比5.35%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20257,023年增 +3.4%
毛利率202541.4%最新一期
營業利益率202519.4%最新一期
每股盈餘20255.19年增 +5.3%
會計項目走勢20212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%
營業成本合計55.1%57.5%56.3%56.0%58.6%
營業毛利(毛損)44.9%42.5%43.7%44.0%41.4%
營業毛利(毛損)淨額44.9%42.5%43.7%44.0%41.4%
推銷費用14.7%12.8%12.7%12.1%12.1%
管理費用5.9%6.0%6.6%6.9%6.2%
研究發展費用5.3%4.3%4.3%4.2%3.7%
預期信用減損損失(利益)0.0%0.3%-0.1%0.2%-0.0%
營業費用合計25.9%23.4%23.5%23.5%22.0%
營業利益(損失)19.0%19.1%20.2%20.6%19.4%
利息收入0.1%0.5%1.1%0.6%0.4%
其他收入3.7%0.9%1.6%2.3%2.1%
其他利益及損失淨額-0.5%2.7%-0.1%0.9%-0.2%
財務成本淨額0.2%0.3%0.4%0.2%0.1%
採用權益法認列之關聯企業及合資損益之份額淨額-0.1%1.0%0.7%-0.2%-0.1%
營業外收入及支出合計3.0%4.8%2.9%3.4%2.2%
稅前淨利(淨損)22.0%23.9%23.0%24.0%21.6%
所得稅費用(利益)合計3.8%4.2%4.5%4.9%3.7%
繼續營業單位本期淨利(淨損)18.2%19.7%18.6%19.1%17.9%
本期淨利(淨損)18.2%19.7%18.6%19.1%17.9%
確定福利計畫之再衡量數0.4%0.6%0.1%0.6%0.3%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-0.5%-0.2%2.4%1.3%-3.1%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目0.0%0.0%-0.0%-0.0%-0.0%
與不重分類之項目相關之所得稅0.1%0.1%0.0%0.1%0.1%
不重分類至損益之項目:-0.1%0.3%2.5%1.8%-2.9%
國外營運機構財務報表換算之兌換差額-0.0%0.3%-0.0%0.2%-0.1%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-0.1%0.0%-0.0%0.0%0.0%
後續可能重分類至損益之項目:-0.1%0.3%-0.0%0.2%-0.0%
其他綜合損益(淨額)-0.2%0.6%2.5%2.0%-2.9%
本期綜合損益總額18.0%20.3%21.0%21.1%15.0%
母公司業主(淨利∕損)15.4%13.9%13.4%13.0%13.2%
非控制權益(淨利∕損)2.8%5.8%5.2%6.1%4.7%
母公司業主(綜合損益)15.1%14.4%15.9%14.9%10.3%
非控制權益(綜合損益)2.8%5.9%5.2%6.1%4.7%
基本每股盈餘0.1%0.1%0.1%0.1%0.1%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%0.0%
稀釋每股盈餘0.1%0.1%0.1%0.1%0.1%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。